Open positions Full portfolio →
| Ticker | Shares | Entry | Stop | Cost | % book |
|---|---|---|---|---|---|
HUBS  | 16 | $178.48 | $142.78 | $2,855.68 | 2.9% |
| MMSI | 48 | $62.74 | $50.19 | $3,011.52 | 3.1% |
| EVTC | 130 | $23.09 | $18.47 | $3,001.70 | 3.1% |
| NSP | 120 | $30.42 | $24.34 | $3,650.40 | 3.7% |
| SRAD | 150 | $12.97 | $10.38 | $1,945.50 | 1.9% |
| WTW | 12 | $256.67 | $205.34 | $3,080.04 | 3.1% |
| PATK | 35 | $95.23 | $76.20 | $3,333.05 | 3.3% |
| OPCH | 140 | $21.75 | $17.40 | $3,045.00 | 3.0% |
| CSGP | 85 | $34.50 | $27.60 | $2,932.50 | 2.9% |
| SPGI | 7 | $429.82 | $343.86 | $3,008.74 | 3.0% |
| GEHC | 55 | $60.87 | $48.70 | $3,347.85 | 3.3% |
| SON | 81 | $49.55 | $39.65 | $4,013.68 | 4.0% |
| WASH | 100 | $31.64 | $25.30 | $3,164.00 | 3.2% |
| CHTR | 25 | $163.55 | $135.00 | $4,088.75 | 4.1% |
| BMI | 33 | $120.08 | $96.00 | $3,962.64 | 4.0% |
| LW | 100 | $43.38 | $35.00 | $4,338.00 | 4.3% |
- May 13, 2026
HubSpot's CEO and CTO bought $2.34 million of stock five trading days after a Q1 print that beat earnings but cut guidance on AI-related demand softness, with the stock at a 52-week low and forward P/E at 11.4× — the lowest multiple in the company's public history.
- May 13, 2026
Merit Medical's new CEO, CFO, and two other officers bought $474,108 combined within three trading days of each other, seven months after the predecessor CEO sold approximately $5.2 million between $84 and $88, at a price that is the lowest open-market officer-purchase basis in five years.
- May 13, 2026
Evertec's COO, EVP, and General Counsel bought $1.36 million combined within four trading days, with the same three executives having sold approximately $1.8 million at $34–37 over the prior twelve months — a coordinated reversal from net seller to net buyer at a 35% lower price.
- May 8, 2026
Insperity's chairman and CEO bought another $2.9 million of stock five days after a Q1 print that beat consensus but cut full-year guidance, extending a March-to-May accumulation pattern that now totals roughly $7.6 million across his own purchases plus those of the CFO, general counsel, and a director.
- May 8, 2026
Sportradar's CEO bought roughly $10 million of stock across three separate days following a Q1 revenue beat and a $250 million buyback announcement, with seven directors filing alongside him in the same window a Muddy Waters and Callisto short report alleged the company derives revenue from illegal gambling operators.
- May 8, 2026
Willis Towers Watson's CEO and Risk & Broking president bought a combined $1.0 million of stock the week after a Q1 beat that nonetheless sent the stock down 12 percent on negative free cash flow and Middle East volatility.
- May 6, 2026
Patrick Industries' CEO, CFO, and RV-division president combined to buy $1.47 million of stock six days after a Q1 print where the company outgrew an RV industry whose wholesale shipments fell 12 percent.
- May 5, 2026
Option Care Health's CEO and CFO bought a combined $592,000 of stock four trading days after the company missed Q1 revenue, cut its full-year guide, and saw the stock drop 26% in a single session.
- May 5, 2026
CoStar Group's founder-CEO doubled his open-market buying with a $2.5 million purchase at a 52-week low, 21% below the price he paid for $2.5 million worth of stock two months earlier.
- May 5, 2026
S&P Global's CEO, the CEO of its S&P Dow Jones Indices subsidiary, and a director combined to buy $2.58 million of stock in the week before the Mobility Global spin-off Investor Day.
- May 1, 2026
GE HealthCare's CEO, CFO, and General Counsel bought $556,000 of stock the day after the company cut its 2026 profit guidance.
- April 30, 2026
Sonoco's CFO bought $400,000 of stock on a Friday. The head of paper packaging bought $340,000 the following Monday.
- April 30, 2026
Three Washington Trust officers bought $1.15M of stock the week the bank reported a Q1 miss and provisioned $4M for two office loans.
- April 29, 2026
Two Charter insiders bought $1.4M on Tuesday. The stock fell 5% on Wednesday.
- April 29, 2026
Five Badger Meter officers sold near the 2025 high. The same five are buying near the 2026 low.
- April 29, 2026
Six insider buys at Lamb Weston in eleven weeks, including a $16M activist position.